Cite
Yeh TK, Song JS, Chang PW, et al. Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design. Eur J Med Chem. 2021;229:114043doi: 10.1016/j.ejmech.2021.114043.
Yeh, T. K., Song, J. S., Chang, P. W., Yu, J. C., Chang, C. H., Liao, F. Y., Tien, Y. W., Kuppusamy, R., Li, A. S., Chen, C. H., Chen, C. W., Lin, L. M., Chang, H. H., Huang, C. H., Yao, J. Y., Wu, M. H., Peng, Y. H., Hsueh, C. C., Hsiao, W. C., Chen, P. H., Lin, C. Y., Hsieh, S. H., Shih, C., Hung, M. S., Wu, S. Y., Kuo, C. C., & Ueng, S. H. (2021). Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design. European journal of medicinal chemistry, 229114043. https://doi.org/10.1016/j.ejmech.2021.114043
Yeh, Teng-Kuang, et al. "Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design." European journal of medicinal chemistry vol. 229 (2021): 114043. doi: https://doi.org/10.1016/j.ejmech.2021.114043
Yeh TK, Song JS, Chang PW, Yu JC, Chang CH, Liao FY, Tien YW, Kuppusamy R, Li AS, Chen CH, Chen CW, Lin LM, Chang HH, Huang CH, Yao JY, Wu MH, Peng YH, Hsueh CC, Hsiao WC, Chen PH, Lin CY, Hsieh SH, Shih C, Hung MS, Wu SY, Kuo CC, Ueng SH. Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design. Eur J Med Chem. 2021 Dec 08;229:114043. doi: 10.1016/j.ejmech.2021.114043. Epub 2021 Dec 08. PMID: 34929581.
Copy
Download .nbib